COMMUNIQUÉS West-GlobeNewswire

Daré Bioscience announces funding award to further the development of Ovaprene™ from the National Institutes of Health Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)

30/04/2018 - 14:00

SAN DIEGO, April 30, 2018 (GLOBE NEWSWIRE) -- Daré Bioscience, Inc. (NASDAQ: DARE ), a clinical-stage, women’s biopharmaceutical company, today announced that it received a Notice of Award for the first $224,665 of the [...]

Orion has completed the sale of Orion Diagnostica business division

30/04/2018 - 11:16

ORION CORPORATION PRESS RELEASE 30 April 2018 at 12.15 p.m. Orion has completed the sale of Orion Diagnostica business division Orion Corporation has completed the sale of all shares in Orion Diagnostica Oy (i.e. the [...]

Election of the Board of Directors on the annual general meeting

30/04/2018 - 10:54

Company announcement 30 April 2018 On 27 April 2018, NeuroSearch A/S ("NeuroSearch") received a notice from Gefion Group Investments A/S ("Gefion") that Gefion had decided to launch a conditional, voluntary takeover [...]

Transactions under Novozymes’ stock buyback program

30/04/2018 - 10:41

Please read the full announcement in the attached PDF Attachment 2018_19_Stock_Buybackprogram_EN

Trading by management and close relations of management

30/04/2018 - 10:36

Read the full announcement in the attached file Attachment 2018_18_Trading_by_management_EN

Changes to Biohit Oyj’s Management Team

30/04/2018 - 10:00

Biohit Oyj, Stock exchange release, April 30, 2018 at 11:00 am local time (EET) M.Sc. (Econ) Jukka Kainulainen (b. 1982) has been appointed Chief Financial Officer and as a member of the Management Team of Biohit Oyj [...]

Curetis Announces Change of the Composition of Its Supervisory Board

30/04/2018 - 07:31

Curetis Announces Change of the Composition of Its Supervisory Board Dr. Holger Reithinger resigns as member of the Supervisory Board Company exploring options to further evolve Board at upcoming 2018 AGM Amsterdam, the [...]

ABLYNX ANNOUNCES WARRANT EXERCISE

30/04/2018 - 07:16

REGULATED INFORMATION GHENT, Belgium, 30 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in conformity with Title II of the Law of 2 May 2007 and the Royal Decree of 14 February 2008, that an [...]

PUBLICATION IN ACCORDANCE WITH ARTICLE 14 OF THE BELGIAN LAW OF 2 MAY 2007 REGARDING THE PUBLICATION OF MAJOR SHAREHOLDINGS (THE "TRANSPARENCY LAW")

30/04/2018 - 07:11

REGULATED INFORMATION GHENT, Belgium, 30 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced, in accordance with Article 14 of the Belgian Law of 2 May 2007 regarding the publication of major [...]

Sanofi: FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma

30/04/2018 - 07:02

Press Release Source: Sanofi (EURONEXT: SAN) (NYSE: SNY) FDA to Conduct Priority Review of Cemiplimab as a Potential Treatment for Advanced Cutaneous Squamous Cell Carcinoma Paris and Tarrytown, NY - April 30, 2018 - [...]

Sanofi : FDA accorde un examen prioritaire au cemiplimab dans le traitement potentiel du carcinome épidermoïde cutané au stade avancé

30/04/2018 - 07:02

Communiqué de presse Source : Sanofi (EURONEXT : SAN) (NYSE : SNY) FDA accorde un examen prioritaire au cemiplimab dans le traitement potentiel du carcinome épidermoïde cutané au stade avancé Paris et Tarrytown (New [...]

Addex Reports 2017 Full Year Results and Provides Corporate Update

30/04/2018 - 07:01

Robust cash position of CHF45 million following capital raise in Q1 2018 Major global licensing agreement with Indivior in addiction Geneva, Switzerland, 30 April 2018 - Addex Therapeutics (SIX: ADXN), a leading company [...]

Innate Pharma to hold its AGM on May 29, 2018 and the release of its Reference document

30/04/2018 - 07:01

Innate pharma TO hold ITS annual general meeting of shareholders on May 29, 2018 and THE RELEASE OF ITS REFERENCE DOCUMENT (IN FRENCH) Marseille, France, April 30, 2018 Innate Pharma (the "Company" - Euronext Paris: [...]

Innate Pharma annonce la tenue de son AG annuelle le 29 mai 2018 et la mise à disposition de son DDR 2017

30/04/2018 - 07:01

INNATE PHARMA ANNONCE LA TENUE DE SON ASSEMBLEE GENERALE ANNUELLE LE 29 MAI 2018 A MARSEILLE ET LA MISE A DISPOSITION DE SON DOCUMENT DE REFERENCE 2017 Marseille, le 30 avril 2018 Innate Pharma (Euronext Paris : [...]

ABLYNX COMPLETES PATIENT RECRUITMENT IN THE PHASE IIb RESPIRE STUDY OF ITS INHALED ANTI-RSV NANOBODY ALX-0171

30/04/2018 - 07:01

REGULATED INFORMATION - INSIDE INFORMATION GHENT, Belgium, 30 April 2018 - Ablynx [Euronext Brussels and Nasdaq: ABLX] today announced that it has successfully completed patient recruitment in the Phase IIb RESPIRE dose [...]

Curetis Publishes Full-Year 2017 Financial Results and Updated Guidance For 2018

30/04/2018 - 07:01

Curetis Publishes Full-Year 2017 Financial Results and Updated Guidance For 2018 - Received U.S. FDA clearance for Unyvero System and Unyvero LRT Cartridge; commercial U.S. roll-out initiated - Launched two novel CE-IVD [...]

LADAVRU® RECEIVES APPROVED FOR PUBLICATON NOTICE FROM THE UNITED STATES PATENT AND TRADEMARK OFFICE (USPTO) HOVERINK BIOTECHNOLOGIES ANNOUNCES.

30/04/2018 - 00:53

LOS ANGELES, CA, April 29, 2018 (GLOBE NEWSWIRE) -- Hoverink Biotechnologies, Inc announced today it has received its Notice of publication from the UNITED STATES PATENT AND TRADEMARK OFFICE for LADAVRU® Serial Number [...]

Flexion Therapeutics Announces Presentation of Positive FX201 Data at the Osteoarthritis Research Society International World Congress

29/04/2018 - 15:00

Results from preclinical osteoarthritis (OA) models demonstrate relief of pain, functional improvement and suggest disease-modifying efficacy following a single intra-articular injection BURLINGTON, Mass., April 29, [...]

HOVERINK BIOTECHNOLOGIES INITIATES PRIVATE PLACEMENT OF CONVERTIBLE NOTES

28/04/2018 - 03:22

LOS ANGELES, CA, April 27, 2018 (GLOBE NEWSWIRE) -- Hoverink Biotechnologies, Inc announced today it intends to offer, subject to market and other conditions, $2.5 million of Series A Convertible Notes, through a [...]